Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$42.05 - $47.77 $1.37 Million - $1.56 Million
-32,600 Reduced 0.33%
9,979,321 $434 Million
Q1 2022

May 13, 2022

SELL
$40.23 - $47.74 $8.59 Million - $10.2 Million
-213,500 Reduced 2.09%
10,011,921 $436 Million
Q4 2021

Feb 11, 2022

BUY
$38.88 - $45.31 $31.5 Million - $36.7 Million
811,000 Added 8.61%
10,225,421 $451 Million
Q3 2021

Nov 12, 2021

BUY
$38.79 - $43.16 $13.7 Million - $15.2 Million
353,100 Added 3.9%
9,414,421 $360 Million
Q2 2021

Aug 13, 2021

BUY
$36.52 - $41.46 $10.9 Million - $12.4 Million
298,300 Added 3.4%
9,061,321 $361 Million
Q1 2021

May 13, 2021

SELL
$34.27 - $40.01 $189 Million - $220 Million
-5,508,400 Reduced 38.6%
8,763,021 $313 Million
Q4 2020

Feb 10, 2021

SELL
$34.07 - $39.94 $138 Million - $162 Million
-4,058,233 Reduced 22.14%
14,271,421 $525 Million
Q3 2020

Nov 13, 2020

SELL
$38.11 - $42.99 $84.7 Million - $95.5 Million
-2,221,600 Reduced 10.81%
18,329,654 $690 Million
Q2 2020

Aug 13, 2020

SELL
$37.87 - $43.58 $95.6 Million - $110 Million
-2,525,200 Reduced 10.94%
20,551,254 $838 Million
Q1 2020

May 14, 2020

BUY
$32.47 - $48.83 $131 Million - $198 Million
4,048,855 Added 21.28%
23,076,454 $874 Million
Q4 2019

Feb 13, 2020

BUY
$42.0 - $48.25 $62 Million - $71.2 Million
1,475,900 Added 8.41%
19,027,599 $894 Million
Q3 2019

Nov 13, 2019

BUY
$40.46 - $43.52 $92.7 Million - $99.7 Million
2,289,918 Added 15.0%
17,551,699 $749 Million
Q2 2019

Aug 12, 2019

BUY
$39.4 - $42.7 $39 Million - $42.2 Million
989,181 Added 6.93%
15,261,781 $611 Million
Q1 2019

May 14, 2019

BUY
$38.57 - $42.69 $101 Million - $112 Million
2,630,200 Added 22.59%
14,272,600 $596 Million
Q4 2018

Feb 13, 2019

BUY
$37.8 - $42.69 $440 Million - $497 Million
11,642,400 New
11,642,400 $445 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.2B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.